403,691 Shares in Viemed Healthcare, Inc. $VMD Purchased by Raffles Associates LP

Raffles Associates LP acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, according to its most recent filing with the SEC. The firm acquired 403,691 shares of the company’s stock, valued at approximately $4,602,000. Viemed Healthcare comprises about 4.2% of Raffles Associates LP’s holdings, making the stock its 8th largest position.

A number of other large investors also recently bought and sold shares of VMD. Hsbc Holdings PLC acquired a new stake in shares of Viemed Healthcare in the 2nd quarter worth $434,000. Expect Equity LLC purchased a new position in Viemed Healthcare during the second quarter worth about $2,425,000. PDT Partners LLC purchased a new position in Viemed Healthcare during the second quarter worth about $268,000. Legal & General Group Plc purchased a new position in shares of Viemed Healthcare during the 2nd quarter worth approximately $97,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Viemed Healthcare in the second quarter valued at approximately $119,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on VMD. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 5th. Weiss Ratings downgraded shares of Viemed Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, August 17th. Barrington Research began coverage on shares of Viemed Healthcare in a report on Monday. They issued an “outperform” rating and a $14.00 target price for the company. Finally, Wall Street Zen downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Viemed Healthcare has a consensus rating of “Hold” and an average price target of $14.00.

Viemed Healthcare Stock Up 0.1%

Shares of NASDAQ VMD opened at $9.10 on Wednesday. Viemed Healthcare, Inc. has a 12-month low of $6.05 and a 12-month high of $12.61. The company has a market capitalization of $346.62 million, a PE ratio of 25.28 and a beta of 1.10. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.02. The firm’s 50-day moving average is $10.92 and its two-hundred day moving average is $9.89.

Viemed Healthcare (NASDAQ:VMD) last posted its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The company had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Equities analysts anticipate that Viemed Healthcare, Inc. will post 0.42 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the sale, the director owned 75,518 shares in the company, valued at approximately $868,457. This trade represents a 20.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider William Frazier sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares of the company’s stock, valued at $858,068.08. The trade was a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is owned by company insiders.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.